Taiwan FDA registration f5bf7315fe0dbb2b4ba419e71a0bef9f
BD PAXgene Blood RNA Tube
TW: BD PAXgene 血液核醣核酸採集保存管
Taiwan·Risk Class 2·MD·BECTON DICKINSON AND COMPANY·Registered Oct 31, 2018 – Oct 31, 2028ActiveRegistration details
- Analysis ID
- f5bf7315fe0dbb2b4ba419e71a0bef9f
- License Form
- Ministry of Health Medical Device Import No. 031766
- Customs Code
- DHA05603176608
Company information
- Manufacturer
- BECTON DICKINSON AND COMPANY
- Manufacturer Country
- United Kingdom
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
Product details
- Intended Use
- Used to collect, store, and deliver blood in reverse transcription polymerase chain reaction used in molecular diagnostic tests to stabilize intracellular RNA (ribonucleic acid) in closed tubes.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C4070 Ribonucleic acid analysis pretreatment system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 31, 2018
- Expiry Date
- Oct 31, 2028
About this record
Access comprehensive regulatory information for BD PAXgene Blood RNA Tube in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f5bf7315fe0dbb2b4ba419e71a0bef9f and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices